AMW GmbH (Arzneimittelwerk Warngau) has secured follow-up financing to advance the development and marketing process for its drug delivery systems. BayBG Bayerische Beteiligungsgesellschaft, UnternehmerTUM Fund and IBG Beteiligungsgesellschaft are joining existing investors to inject up to seven million euro.
